MedTrace Logo

Carolinas Cardiogenic Shock Initiative

NCT04985708 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-06-06

No results posted yet for this study

Summary

To determine if deferred or delayed implantation of Impella device based on shock severity index is non-inferior with respect to 1 month and 1 year mortality compared to standard clinical protocols that do not differentiate based on shock severity in adult patients following an initial diagnosis of acute myocardial infarction complicated by cardiogenic shock (AMICS).

Conditions

  • Cardiogenic Shock
  • Acute; Myocardial Infarction, Complications

Interventions

OTHER

data collection of clinically available procedures

when to place Impella related to PCI in patients with AMICS

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Glen J Kowalchuk, MD · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04985708 on ClinicalTrials.gov